Stock-Based Compensation for Johnson & Johnson (JNJ)
Stock-Based Compensation for Johnson & Johnson (JNJ): headline value $1.37B · YoY +15.1%. Annual and quarterly series, chart, and tables are below.
Headline figure above is from the reporting period ending (reported ). Chart and table below cover the full reported history back to .
Currently viewingStock-Based CompensationSwitch metric
Latest period
$1.37B
YoY change
+15.1%
5Y CAGR
+6.1%
Peak year (2025)
$1.35B
Latest annual
$1.35B
Stock-Based Compensation history chart for Johnson & Johnson (JNJ) from 1989 to 2025
Stock-Based Compensation history table for Johnson & Johnson (JNJ) from 1989 to 2025
| Fiscal year | Period ended | Reported | Stock-Based Compensation | YoY |
|---|---|---|---|---|
| 2025 | $1.35B | +15.1% | ||
| 2024 | $1.18B | +1.2% | ||
| 2023 | $1.16B | +2.1% | ||
| 2022 | $1.14B | +0.3% | ||
| 2021 | $1.14B | +12.9% | ||
| 2020 | $1.00B | +2.9% | ||
| 2019 | $977.00M | -0.1% | ||
| 2018 | $978.00M | +1.7% | ||
| 2017 | $962.00M | +9.6% | ||
| 2016 | $878.00M | +0.5% | ||
| 2015 | $874.00M | +10.4% | ||
| 2014 | $792.00M | +8.8% | ||
| 2013 | $728.00M | +10.0% | ||
| 2012 | $662.00M | +6.6% | ||
| 2011 | $621.00M | +1.1% | ||
| 2010 | $614.00M | -2.2% | ||
| 2009 | $628.00M | +0.2% | ||
| 2008 | $627.00M | -10.2% | ||
| 2007 | $698.00M | — | ||
| 2006 | $0 | — | ||
| 2005 | $0 | — | ||
| 2004 | $0 | — | ||
| 2003 | $0 | — | ||
| 2002 | $0 | — | ||
| 2001 | $0 | — | ||
| 2000 | $0 | — | ||
| 1999 | $0 | — | ||
| 1998 | $0 | — | ||
| 1997 | $0 | — | ||
| 1996 | $0 | — | ||
| 1995 | $0 | — | ||
| 1994 | $0 | — | ||
| 1993 | $0 | — | ||
| 1992 | $0 | — | ||
| 1991 | $0 | — | ||
| 1990 | $0 | — | ||
| 1989 | $0 | — |
Stock-Based Compensation values are taken from Johnson & Johnson's reported cash flow statements (10-Q quarterly and 10-K annual filings with the U.S. Securities and Exchange Commission). Each row shows the period end date and the date the filing was reported; YoY compares each figure to the same period one year earlier. Amounts are in USD as filed.
Analysis
2025's annual stock-based compensation for Johnson & Johnson (JNJ) came in at $1.35B – grew 15.1% year-over-year.
Johnson & Johnson stock-based compensation has recorded the values shown across consecutive periods, with a +6.1% compound annual growth rate over 2020–2025 (5 years).
The highest annual stock-based compensation of $1.35B was reported in 2025. The lowest in the available history was $0 in 1989.
Among 8 Healthcare peers, Johnson & Johnson (JNJ) ranks 1st; the peer median for stock-based compensation is $0.
Johnson & Johnson Stock-Based Compensation by Year
Johnson & Johnson Stock-Based Compensation 2025: $1.35B
Johnson & Johnson stock-based compensation in 2025 was $1.35B, grew 15.1% from 2024. This figure represents the highest annual value in the available history.
Johnson & Johnson Stock-Based Compensation 2024: $1.18B
Johnson & Johnson stock-based compensation in 2024 was $1.18B, edged up 1.2% from 2023.
Johnson & Johnson Stock-Based Compensation 2023: $1.16B
Johnson & Johnson stock-based compensation in 2023 was $1.16B, edged up 2.1% from 2022.
Johnson & Johnson Stock-Based Compensation 2022: $1.14B
Johnson & Johnson stock-based compensation in 2022 was $1.14B, edged up 0.3% from 2021.
Johnson & Johnson Stock-Based Compensation 2021: $1.14B
Johnson & Johnson stock-based compensation in 2021 was $1.14B.
See more financial history for Johnson & Johnson (JNJ).
Sector peers — Stock-Based Compensation
Companies in the same sector as Johnson & Johnson, ranked by their latest stock-based compensation.
| Company | Stock-Based Compensation | Sector |
|---|---|---|
| UnitedHealth Group Incorporated (UNH) | $971.00M | Healthcare |
| AbbVie Inc. (ABBV) | $955.00M | Healthcare |
| Eli Lilly and Company (LLY) | $626.00M | Healthcare |
| AstraZeneca PLC (AZN) | $0 | Healthcare |
| Merck & Co., Inc. (MRK) | $0 | Healthcare |
| Amgen Inc. (AMGN) | $0 | Healthcare |
| Novo Nordisk A/S (NVO) | $0 | Healthcare |
| Thermo Fisher Scientific Inc. (TMO) | $0 | Healthcare |
Frequently asked questions
What is Johnson & Johnson's stock-based compensation?
Latest reported stock-based compensation for Johnson & Johnson (JNJ) is $1.37B (period ending March 29, 2026).
How has Johnson & Johnson stock-based compensation changed year-over-year?
Johnson & Johnson (JNJ) stock-based compensation changed +15.1% year-over-year on the latest annual filing.
What is the long-term growth rate of Johnson & Johnson stock-based compensation?
Johnson & Johnson (JNJ) stock-based compensation compound annual growth rate is +6.1% over the most recent 5 years available.
When did Johnson & Johnson stock-based compensation hit its highest annual value?
Johnson & Johnson stock-based compensation reached its highest annual value of $1.35B in 2025.
What was Johnson & Johnson stock-based compensation in 2024?
Johnson & Johnson (JNJ) stock-based compensation in 2024 was $1.18B.
What was Johnson & Johnson stock-based compensation in 2025?
Johnson & Johnson (JNJ) stock-based compensation in 2025 was $1.35B.
Metrics overview
Pick a metric for charts, filings and peers — each row shows the latest TTM or most-recent-quarter value.
Explore more
JNJ Overview
Company profile, financial tools, and key metrics
JNJ Revenue Counter
Earns $3,066 every second. See per minute, hour, and day.
JNJ Earnings Counter
Earns $657.60 per second net profit. See per minute, hour, and day.
JNJ Economic Scale
Exceeds Costa Rica's GDP. Compare with world economies.
JNJ What If Invested
What if you had invested $1,000? See historical returns from any date.
JNJ How It Makes Money
Discover visual breakdown of $96.68B in revenue — where it comes from and where it goes.
JNJ Stock Seasonality
Best and worst months to invest. Historical monthly returns heatmap.
JNJ Price Target Scenarios
Model bear, base, and bull cases with EPS growth and exit P/E — pre-filled from analysts and history.
JNJ Daily Price Character
Steady · 47.0% historical win rate (green days). Streaks & record days.
JNJ Buybacks
1.00% TTM buyback yield. Shareholder yield & SBC comparison.
JNJ Stock Split History
7 splits on record. Dates, ratios, and cumulative multiple.
JNJ Dividend Profile
Yield: 2.29%. Safety: 6/8. See full history.
JNJ Dividend Calculator
How much dividend income would $1,000 have earned? Calculate from any date.
JNJ Dividend Forecast
Project future income with DRIP, growth assumptions, and optional monthly contributions.